Driehaus Capital Management’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Driehaus Capital Management’s Portfolio ORTX Stock Details ORTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-2,324	Closed	-$169K	–	538
2021 Q1	$169K	Sell	2,324 -46,196	-95%	-$3.28M	﹤0.01%	435
2020 Q4	$2.1M	Buy	48,520 +4,711	+11%	+$211K	0.03%	287
2020 Q3	$1.8M	Hold	43,809	–	–	0.04%	263
2020 Q2	$2.63M	Sell	43,809 -100,265	-70%	-$9.19M	0.06%	247
2020 Q1	$10.8M	Sell	144,074 -3,308	-2%	-$381K	0.36%	79
2019 Q4	$20.3M	Buy	147,382 +1,277	+0.9%	+$155K	0.54%	47
2019 Q3	$17.4M	Buy	146,105 +3,168	+2%	+$442K	0.56%	43
2019 Q2	$20M	Buy	142,937 +56,323	+65%	+$9.89M	0.63%	44
2019 Q1	$15.5M	Buy	86,614 +916	+1%	+$138K	0.58%	44
2018 Q4	$13.5M	Buy	+85,698	New	+$12.8M	0.58%	42

Other funds holding ORTX

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Driehaus Capital Management's ORTX Position: Q2 2021 in Review

Driehaus Capital Management sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q2 2021, closing a stake of 2,324 shares — an estimated $169K sold.

Driehaus Capital Management first reported a position in ORTX in Q4 2018 and held it in 10 quarters. The position peaked at $20.3M in Q4 2019. 85 funds tracked by Wall St. Rank hold ORTX as of Q2 2021.

Driehaus Capital Management reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
Driehaus Capital Management sold 2,324 Orchard Therapeutics plc American Depositary Shares shares in Q2 2021, an estimated $169K.
Driehaus Capital Management first reported a position in Orchard Therapeutics plc American Depositary Shares in Q4 2018 and held it in 10 quarters.
Driehaus Capital Management's Orchard Therapeutics plc American Depositary Shares position peaked at $20.3M in Q4 2019.
85 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q2 2021.

Based on Driehaus Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.